source
- UK issues AI-in-medicine regulatory recommendations; FDA pauses new enrollment in Biohaven epilepsy trialsThe United Kingdom has released a set of recommendations aimed at governing the use of artificial intelligence in medical applications. The guidance outlines how AI tools should be evaluated and mo…
- Takeda R&D chief Andy Plump to retire in June 2027 after 12-year tenureTakeda announced that its longstanding head of research and development, Andy Plump, will step down and retire in June 2027. Plump has been with the Japanese drugmaker for about 12 years, leading…